source
- Takeda R&D chief Andy Plump to retire in June 2027, will stay on board through 2027Takeda announced that Andy Plump, who has led the company's research and development since 2015, will retire in June 2027. Plump will remain president of R&D until a successor is appointed and wil…
- Tyra Biosciences shares tumble as bladder cancer pill shows lower-than-expected complete responseTyra Biosciences presented Phase 2 SURF302 data for its investigational oral drug dabogratinib in patients with low‑grade intermediate‑risk non‑muscle invasive bladder cancer. The trial reported th…